BioVie (BIVI) Short Interest Ratio & Short Volume

Short interest is the volume of BioVie shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 1,110,000 shares of BIVI short. Learn More on BioVie's current short interest.

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of BioVie: Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

BioVie saw a decline in short interest in April. As of April 15th, there was short interest totaling 1,110,000 shares, a decline of 25.0% from the previous total of 1,480,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to BioVie: Aptorum Group Limited (1.89%), Addex Therapeutics Ltd (2.74%), Alaunos Therapeutics, Inc. (9.51%), RenovoRx, Inc. (0.45%), Galecto, Inc. (0.09%), Vincerx Pharma, Inc. (8.91%), Flora Growth Corp. (7.33%), NeuroSense Therapeutics Ltd. (0.76%), Onconova Therapeutics, Inc. (0.12%), KALA BIO, Inc. (0.21%),

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks.

Short selling BIVI is an investing strategy that aims to generate trading profit from BioVie as its price is falling. BIVI shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for BioVie occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BIVI, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BIVI, twice per month. The most recent reporting period available is April, 15 2024.